Review
Published on 20 Jan 2021
Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
in Cancer Immunity and Immunotherapy

- 8,297 views
- 13 citations













